Progenics Pharmaceuticals Inc

Formerly NASDAQ: PGNX
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 425 15 pages Support Agreement
12/34/56
EX-10.55
from 10-K 2 pages As You May Know, Progenics Pharmaceuticals, Inc. (The “Company”) Has Recently Entered Into an Agreement to Be Acquired by Lantheus Holdings, Inc. (“Parent,” and Such Acquisition, the “Company Sale”). the Company Is Pleased to Offer You a Total Retention Bonus Opportunity of $[Total Bonus Amount] on the Terms and Conditions Set Forth in This Letter Agreement. Your Total Retention Bonus Opportunity Consists of Two Parts
12/34/56
EX-10.54
from 10-K 7 pages Consulting Services Agreement Progenics Contract No. 000000
12/34/56
EX-10.51
from 10-K 2 pages Material contract
12/34/56
EX-10.50
from 10-K 2 pages Material contract
12/34/56
EX-10.48
from 10-K 2 pages Material contract
12/34/56
EX-10.1
from 8-K 7 pages Consulting Services Agreement March 4, 2020
12/34/56
EX-10.1
from 425 20 pages Form of Contingent Value Rights Agreement Between Lantheus Holdings, Inc. and [●] as Rights Agent Dated as of [●], 2020
12/34/56
EX-10.6
from 10-Q 5 pages Non-Qualified Stock Option Award Agreement Progenics Pharmaceuticals, Inc. 2018 Performance Incentive Plan – Grant #Number
12/34/56
EX-10.5
from 10-Q 5 pages Non-Qualified Stock Option Award Agreement Progenics Pharmaceuticals, Inc. 2018 Performance Incentive Plan – Grant #Number
12/34/56
EX-10.1
from 8-K 4 pages Amendment to Stock Purchase and Sale Agreement
12/34/56
EX-10.1
from 8-K 15 pages Progenics Pharmaceuticals, Inc. 2018 Performance Incentive Plan
12/34/56
EX-10.1
from 8-K 37 pages Confidential Settlement and License Agreement
12/34/56
EX-10.1
from 8-K 32 pages Confidential Settlement and License Agreement
12/34/56
EX-10.1
from 8-K 8 pages Assignment and Assumption Agreement
12/34/56
EX-10.1
from 8-K 55 pages License Agreement
12/34/56
EX-10.49
from 10-K 6 pages Material contract
12/34/56
EX-10.48
from 10-K 6 pages Material contract
12/34/56
EX-10.47
from 10-K 34 pages Exclusive License Agreement
12/34/56
EX-10.1
from 8-K 3 pages Definitions; Premises; Term
12/34/56